Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies
Open Access
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 6 (4) , 157-162
- https://doi.org/10.1016/s1357-4310(00)01677-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Oxygenation predicts radiation response and survival in patients with cervix cancerRadiotherapy and Oncology, 1998
- The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target.Cancer and Metastasis Reviews, 1998
- Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neckInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Hypoxia-specific cytotoxins in cancer therapySeminars in Radiation Oncology, 1996
- Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neckRadiotherapy and Oncology, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trialsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Mitomycin-C as a prototype bioreductive alkylating agent: In vitro studies of metabolism and cytotoxicityInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Potential bioreductive alkylating agents. 1. Benzoquinone derivativesJournal of Medicinal Chemistry, 1972
- The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in RadiotherapyThe British Journal of Radiology, 1953